In vivo imaging of bile accumulation and biliary infarction after common bile duct ligation in rats

European Surgical Research

Volumn 47, Issue 4, 2011, Pages 240-247

  Harnoss, J C ^a,b   Heidecke, C D ^c   Vollmar, B ^a   Eipel, C ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Autofluorescence; Cholestasis; Common bile duct ligation; Fibrosis; In vivo imaging

Indexed keywords

BILE ACID; FLUORESCENT DYE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIARY INFARCTION; CHOLESTASIS; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; LIVER INJURY; MALE; MOUSE; NONHUMAN; OBSTRUCTIVE CHOLESTASIS; PRIORITY JOURNAL;

ANIMALS; CHOLESTASIS; DISEASE MODELS, ANIMAL; LIVER; MALE; MICROSCOPY, FLUORESCENCE; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80155135675     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000333087     Document Type: Article

References (20)

1. Dooley JS: Extrahepatic biliary obstruction: systemic effects, diagnosis, management; in Bircher J, Benharnou JP, Mc Intyre N, et al (eds): Oxford Textbook of Clinical Hepatology. New York, Oxford University Press, 1999, vol 2.
2. Kinugasa T, Uchida K, Kadowaki M, Takase H, Nomura Y, Saito Y: Effect of bile duct ligation on bile acid metabolism in rats. J Lipid Res 1981; 22: 201-207. (Pubitemid 11125124)
3. Maillette de Buy Wenniger L, Beuers U: Bile salts and cholestasis. Dig Liver Dis 2010; 42: 409-418.
4. Gressner AM: Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules. Z Gastroenterol 1992; 30(suppl 1):5-16.
5. Gressner AM, Bachem MG: Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storing cells. Digestion 1995; 56: 335-346.
6. Eipel C, Eisold M, Schuett H, Vollmar B: Inhibition of heme oxygenase-1 protects against tissue injury in carbon tetrachloride exposed livers. J Surg Res 2007; 139: 113-120. (Pubitemid 46482571)
7. Suematsu M, Oda M, Suzuki H, Kaneko H, Watanabe N, Furusho T, Masushige S, Tsuchiya M: Intravital and electron microscopic observation of Ito cells in rat hepatic microcirculation. Microvasc Res 1993; 46: 28-42.
8. Haber B, Ferreira CT, Aw M, Bezerra J, Sturm E, Thompson R, D'Agostino D, Mc- Kiernan P: Cholestasis: current issues and plan for the future. J Pediatr Gastroenterol Nutr 2008; 47: 220-224.
9. Hirschfield GM, Heathcote EJ: Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol 2009; 25: 175-179.
10. Popper H: Cholestasis: the future of a past and present riddle. Hepatology 1981; 1: 187-191. (Pubitemid 11055080)
11. Kosters A, Karpen SJ: The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis 2010; 30: 186-194.
12. Haga Y, Kay HD, Tempero MA, Zetterman RK: Flow cytometric measurement of intracellular bilirubin in human peripheral blood mononuclear cells exposed to unconjugated bilirubin. Clin Biochem 1992; 25: 277-283.
13. Li FC, Liu Y, Huang GT, Chiou LL, Liang JH, Sun TL, Dong CY, Lee HS: In vivo dynamic metabolic imaging of obstructive cholestasis in mice. Am J Physiol Gastrointest Liver Physiol 2009; 296:G1091-G1097.
14. Lalisang TJ, Sjamsuhidajat R, Siregar NC, Taher A: Profile of hepatocyte apoptosis and bile lakes before and after bile duct decompression in severe obstructive jaundice patients. Hepatobiliary Pancreat Dis Int 2010; 9: 520-523.
15. Shibayama Y: Factors producing bile infarction and bile duct proliferation in biliary obstruction. J Pathol 1990; 160: 57-62. (Pubitemid 20040651)
16. Friedman SL: Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835. (Pubitemid 23174715)
17. Jiao J, Friedman SL, Aloman C: Hepatic fibrosis. Curr Opin Gastroenterol 2009; 25: 223-229.
18. Mathew J, Geerts A, Burt AD: Pathobiology of hepatic stellate cells. Hepatogastroenterology 1996; 43: 72-91. (Pubitemid 26083766)
19. Denk GU, Soroka CJ, Takeyama Y, Chen WS, Schuetz JD, Boyer JL: Multidrug resistanceassociated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol 2004; 40: 585-591. (Pubitemid 38367779)
20. Mennone A, Soroka CJ, Cai SY, Harry K, Adachi M, Hagey L, Schuetz JD, Boyer JL: Mrp4-/- mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology 2006; 43: 1013-1021. (Pubitemid 43724626)